Next Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Next Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Hold	2,000	–	–	0.09%	105
2026 Q1	$255K	Hold	2,000	–	–	0.08%	111
2025 Q4	$244K	Hold	2,000	–	–	0.08%	114
2025 Q3	$200K	Buy	+2,000	New	+$180K	0.07%	125
2023 Q2	–	Sell	-2,000	Closed	-$152K	–	129
2023 Q1	$152K	Buy	+2,000	New	+$166K	0.07%	117
2019 Q4	–	Sell	-1,000	Closed	-$76K	–	225
2019 Q3	$76K	Sell	1,000 -1,500	-60%	-$125K	0.05%	121
2019 Q2	$219K	Hold	2,500	–	–	0.15%	80
2019 Q1	$226K	Hold	2,500	–	–	0.19%	76
2018 Q4	$179K	Buy	+2,500	New	+$201K	0.16%	78

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Next Capital Management's XBI Position: Q2 2026 in Review

Next Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,000 shares worth $317K. The position accounts for 0.09% of the portfolio, ranked #105.

Next Capital Management first reported a position in XBI in Q4 2018 and has held it in 9 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Next Capital Management held 2,000 shares of State Street SPDR S&P Biotech ETF worth $317K as of Q2 2026.
Next Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.09% of Next Capital Management's portfolio in Q2 2026, its #105 holding.
Next Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 9 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Next Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.